AbbVie (ABBV) Announces FDA Approval of EMBLAVEO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. SPY
6. CRDO
7. GOOGL
8. MMED
9. AAPL
10. NVDA

Go back to AbbVie (ABBV) Announces FDA Approval of EMBLAVEO
AbbVie (NYSE: ABBV) Delayed: 259.45 -0.54 (0.21%)
Previous Close $259.99    52 Week High $68.12 
Open $262.70    52 Week Low $50.71 
Day High $262.97    P/E 56.28 
Day Low $258.63    EPS $4.61 
Volume 743,655